Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes
暂无分享,去创建一个
Ville-Petteri Mäkinen | Raija Lithovius | Valma Harjutsalo | Carol Forsblom | Per-Henrik Groop | Iiro Toppila | C. Forsblom | P. Groop | O. B. O. T. I. Group | V. Harjutsalo | V. Mäkinen | on behalf of the FinnDiane Study Group | R. Lithovius | I. Toppila | Raija Lithovius
[1] C. Forsblom,et al. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study , 2011, BMJ : British Medical Journal.
[2] Morten Wang Fagerland,et al. All-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973–2013 , 2015, Diabetologia.
[3] M. Breton,et al. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D , 2015, Journal of diabetes science and technology.
[4] P. Cleary,et al. The Long-Term Effects of Type 1 Diabetes Treatment andComplications on Health-Related Quality of Life A 23-year follow-up of the Diabetes Control and Complications / Epidemiology of Diabetes Interventions and Complications cohort , 2013 .
[5] Tore K Kvien,et al. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis , 2007, BMC Medical Genetics.
[6] Tony Badrick,et al. Higher Dimensions : Machine-Learning and Enhanced Prediction from Routine Clinical Chemistry Data , 2016 .
[7] B. Zinman,et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. , 2015, JAMA.
[8] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[9] M. Woodward,et al. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. , 2015, The lancet. Diabetes & endocrinology.
[10] L. Kuller,et al. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[11] Gretchen A. Piatt,et al. Deficiencies of Cardiovascular Risk Prediction Models for Type 1 Diabetes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.
[12] C. Forsblom,et al. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients , 2003, Diabetologia.
[13] Thomas J. Songer,et al. Improvements in the Life Expectancy of Type 1 Diabetes , 2012, Diabetes.
[14] R. Karas,et al. Molecular and Cellular Basis of Cardiovascular Gender Differences , 2005, Science.
[15] P. Clarke,et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden , 2016, Diabetologia.
[16] J. Shaw,et al. Age-Specific Trends From 2000–2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People , 2016, Diabetes Care.
[17] C. Forsblom,et al. Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes , 2009, Diabetes Care.
[18] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[19] T. Orchard,et al. High-density lipoprotein cholesterol in diabetes: is higher always better? , 2011, Journal of clinical lipidology.
[20] Merlin C. Thomas,et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.
[21] Merlin C. Thomas,et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.
[22] K. Kaski,et al. Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes , 2008, Diabetes.
[23] M. Taskinen,et al. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes , 2009, Diabetologia.
[24] W. Herman,et al. A Meta-Analysis of the Relative Risk of Mortality for Type 1 Diabetes Patients Compared to the General Population: Exploring Temporal Changes in Relative Mortality , 2014, PloS one.
[25] V. Fuster,et al. Cardiovascular risk factors in patients with chronic kidney disease , 2009, Nature Reviews Cardiology.
[26] J. Gross,et al. Diabetic nephropathy: diagnosis, prevention, and treatment. , 2005, Diabetes care.
[27] B. Carstensen,et al. Time trends in mortality rates in type 1 diabetes from 2002 to 2011 , 2013, Diabetologia.
[28] K. Kaski,et al. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death , 2008, Molecular systems biology.
[29] A. Rigby,et al. Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes , 2007, Diabetes Care.
[30] Alex P. Reiner,et al. Mendelian randomization of blood lipids for coronary heart disease , 2014, European heart journal.
[31] John Spertus,et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.
[32] David Meyre,et al. From big data analysis to personalized medicine for all: challenges and opportunities , 2015, BMC Medical Genomics.
[33] K. Secnik,et al. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain , 2005, Current medical research and opinion.
[34] T. Orchard,et al. The Prediction of Major Outcomes of Type 1 Diabetes: a 12-Year Prospective Evaluation of Three Separate Definitions of the Metabolic Syndrome and Their Components and Estimated Glucose Disposal Rate , 2007, Diabetes Care.